Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics (LENZ) Accumulated Depreciation: 2022-2023

Historic Accumulated Depreciation for Therapeutics (LENZ) over the last 2 years, with Sep 2023 value amounting to $838,000.

  • Therapeutics' Accumulated Depreciation fell 66.81% to $838,000 in Q3 2023 from the same period last year, while for Sep 2023 it was $838,000, marking a year-over-year decrease of 66.81%. This contributed to the annual value of $3.2 million for FY2022, which is N/A change from last year.
  • Therapeutics' Accumulated Depreciation amounted to $838,000 in Q3 2023, which was down 74.41% from $3.3 million recorded in Q2 2023.
  • In the past 5 years, Therapeutics' Accumulated Depreciation ranged from a high of $3.9 million in Q1 2023 and a low of $838,000 during Q3 2023.
  • For the 2-year period, Therapeutics' Accumulated Depreciation averaged around $2.4 million, with its median value being $2.5 million (2022).
  • Data for Therapeutics' Accumulated Depreciation shows a peak YoY increase of 198.22% (in 2023) and a maximum YoY decrease of 66.81% (in 2023) over the last 5 years.
  • Over the past 2 years, Therapeutics' Accumulated Depreciation (Quarterly) stood at $3.2 million in 2022, then slumped by 66.81% to $838,000 in 2023.
  • Its Accumulated Depreciation was $838,000 in Q3 2023, compared to $3.3 million in Q2 2023 and $3.9 million in Q1 2023.